N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2 Purity ≥99.0% Argatroban Intermediate
Manufacturer Supply Argatroban Related Intermediates:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
| Chemical Name | N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester |
| Synonyms | Argatroban Intermediate-5 |
| CAS Number | 74874-09-2 |
| CAT Number | RF-PI268 |
| Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
| Molecular Formula | C25H35N7O7S |
| Molecular Weight | 577.65 |
| Shipping Condition | Shipped Under Ambient Temperature |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White or Off-White Crystalline Powder |
| Purity | ≥99.0% |
| Related Substance | ≤2.0% |
| Enantiomorph | ≤0.30% |
| Residual Solvents | |
| Methanol | ≤0.30% |
| Ethanol | ≤0.50% |
| Dichloromethane | ≤0.03% |
| Acetic Ether | ≤0.50% |
| Triethylamine | ≤0.03% |
| Toluene | ≤0.10% |
| Heavy Metals | ≤20ppm |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.20% |
| Test Standard | Enterprise Standard |
| Usage | Argatroban Intermediate-5 |
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Argatroban Intermediate-5, N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester (CAS: 74874-09-2) with high quality, is an intermediate of Argatroban Monohydrate (CAS 141396-28-3) or Argatroban Anhydrous (CAS 74863-84-6).
Argatroban is a new synthetic antithrombotic agent useful in maintenance anticoagulation them ischemic stroke and disseminated intravascular coagulation. Argatroban is an anticoagulant that acts as a potent, seletive, univalent direct inhibitor of thrombin. Argatroban was approved in 2000 for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT).
